Your browser doesn't support javascript.
loading
Propensity Score Analysis of Radical Hysterectomy Versus Definitive Chemoradiation for FIGO Stage IIB Cervical Cancer.
Tomita, Natsuo; Mizuno, Mika; Makita, Chiyoko; Kondo, Shinji; Mori, Masahiko; Sakata, Jun; Tsubouchi, Hirofumi; Hirata, Kimiko; Tachibana, Hiroyuki; Kodaira, Takeshi.
Afiliação
  • Tomita N; Departments of Radiation Oncology and.
  • Mizuno M; Gynecologic Oncology, Aichi Cancer Center Hospital, Nagoya.
  • Makita C; Department of Radiation Oncology, Gifu Prefectural General Medical Center, Gifu.
  • Kondo S; Gynecologic Oncology, Aichi Cancer Center Hospital, Nagoya.
  • Mori M; Gynecologic Oncology, Aichi Cancer Center Hospital, Nagoya.
  • Sakata J; Gynecologic Oncology, Aichi Cancer Center Hospital, Nagoya.
  • Tsubouchi H; Gynecologic Oncology, Aichi Cancer Center Hospital, Nagoya.
  • Hirata K; Department of Radiation Oncology, Kyoto City Hospital, Kyoto, Japan.
  • Tachibana H; Departments of Radiation Oncology and.
  • Kodaira T; Departments of Radiation Oncology and.
Int J Gynecol Cancer ; 28(8): 1576-1583, 2018 10.
Article em En | MEDLINE | ID: mdl-30095702
ABSTRACT

OBJECTIVE:

The aim of this study was to compare the outcomes and toxicities of radical hysterectomy (RH) and definitive chemoradiation (CRT) for International Federation of Gynecology and Obstetrics (FIGO) stage IIB cervical cancer. MATERIALS AND

METHODS:

A retrospective analysis was performed on FIGO stage IIB patients who underwent RH with adjuvant radiotherapy (surgery group) or intended to receive CRT (CRT group). The distributions of disease-free survival (DFS) and overall survival (OS) were calculated using the Kaplan-Meier method. Propensity score matching (PSM) was performed for the 2 groups based on age, tumor diameter, histological type, and pelvic node metastasis in pretreatment imaging tests.

RESULTS:

Median follow-up times were 58 months in the surgery group (n = 75) and 55 months in the CRT group (n = 65). Propensity score matching identified 37 patients with similar characteristics from each group. Significant differences were observed in the ratio of the chemotherapy combination between the surgery and CRT groups before (47% vs 98%) and after PSM (51% vs 100%). Five-year DFS rates were slightly higher in the surgery group than in the CRT group before PSM (69% vs 58%, P = 0.30) but were similar after PSM (76% vs 82%, P = 0.36). Five-year OS rates were similar between the surgery and CRT groups before (70% vs 75%, P = 0.59) and after PSM (78% vs 77%, P = 0.97). The results of multivariate analyses also showed that neither DFS nor OS was associated with the treatment modalities regardless of PSM. The incidence of late toxicities grade 2 or greater was similar between the surgery and CRT groups before (17% vs 23%, P = 0.31) and after PSM (19% vs 24%, P = 0.78).

CONCLUSIONS:

The results of this study suggest that RH with adjuvant radiotherapy and definitive CRT are equivalent treatment options for patients with FIGO stage IIB cancer. However, prospective larger studies are needed to confirm this.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Colo do Útero Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Colo do Útero Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article